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ABST RACT
When a new coronavirus appeared in the late 2019, identified as the cause
of several cases of pneumonia in Wuhan, Paracetamol was initially
reported to be the preferable antipyretic medication, choice which was
detrimental to the use of other drugs. People have resorted to buying large
stocks of Paracetamol and some have used it in large doses, regardless of
the consequences. However, the Paracetamol (Acetaminophen) overdose
remains the leading cause of death or transplantation due to acute liver
failure in many parts of the world. This review aims at presenting the
pharmacokinetics, the clinical signs, and the risk factors for systemic
toxicity associated with Paracetamol overdose, as well as the current
therapeutic approach. Paracetamol is primarily metabolized in the liver, by
glucuronidation and sulfation. In case of a Paracetamol overdose, a large
amount of NAPQI is conjugated with glutathione, and this process is due
to a major depletion of glutathione, thus leading to hepatic necrosis, renal
failure, and encephalopathy. The evaluation of serum acetaminophen
levels by analytical methods is extremely useful both for the diagnosis and
the therapy monitoring.

Introduction
When a new coronavirus appeared in the late 2019,
identified as the cause of several cases of pneumonia in
Wuhan, doctors went on alert to understand the course of the
disease and to identify the optimal treatment solutions [1].
The etiologic agent, called SARS-Cov2, is a newly
discovered ARN virus in the Coronavirus family, generally
responsible for benign respiratory infections, except for the
causative agents of MERS (2012) and SARS (2002-2003)
outbreaks [2,3]. Being a new pathogen and a new disease,
the treatment options were limited, the only solution being
to use drugs already in use, which had proven safe to use on
humans and effective in treating other conditions and, thus,
to improve the symptoms and to support vital functions. The
WHO has issued Guidelines on how to care for patients with
COVID-19, which is still temporary due to the need to adapt
and change in order to keep up with the new emerging data.

Category: Review
Received: December 12, 2021
Accepted: February 19, 2022
Published: April 10, 2022
Keywords:
acetaminophen, overdose, liver failure, analytical methods

*
Corresponding author:
Andreea Cristina Costea,
Diaverum Clinic, Department of Nephrology and Dialysis,
Constanta, Romania, 900612
E-mail: acostea2021@gmail.com

The health crisis generated by COVID-19 is also seen
in the increasing demand for Paracetamol, a drug included
in the therapeutic protocol for mild cases. During this
period, Paracetamol was indicated to be used, which was
detrimental to the use of other drugs. People have resorted
to buying large stocks of Paracetamol and some have used
it in large doses, regardless of the consequences. The
demand for Paracetamol increased by 20% in the first
months after the outbreak. During the pandemic, the
volume of requests for paracetamol increased by more than
110%. Thus, the indication of its use as an antiinflammatory drug, the lack of a prescription, and the ease
in procuring it, led, in some cases, to lethal consequences.
The Paracetamol (acetaminophen) overdose remains
the leading cause of death or transplantation due to acute
liver failure in many parts of the world.
Paracetamol was first made in 1877 and it still is one of
the most commonly used medications for pain and fever [4].
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Acetaminophen is an analgesic, non-morphine compound,
widely used worldwide, due to its pharmacotherapeutic
characteristics and very good tolerance in therapeutic
doses. Acetaminophen is an analgesic drug used alone or
in combination with opioids for pain management, as well
as an antipyretic agent [5]. Paracetamol is close to classical
nonsteroidal anti-inflammatory drugs. Acetaminophen
(Paracetamol, N-acetyl-p-amino-phenol, Tylenol) is used
in its pure form in many trade preparations for oral use or
in combination with other substances, such as codeine and
propoxyphene,
pseudoephedrine,
chlorpheniramine,
ibuprofen, tramadol, and thanks to the analgesic and
antipyretic effects, they are widely used for mild to
moderate pain and fever. Postoperative pain is one of the
main factors of postoperative discomfort and worry in the
first postoperative evening [6]. However, a careful
evaluation of the associated conditions is important in
order to prevent toxicity-related side-effects. The
paracetamol/ibuprofen combination provides a further
increase in potency and it is superior to any drug used alone
[7,8]. The confusion about the dosing of this drug may be
caused by the availability of different formulas, strengths,
and dosage instructions for children of various ages [7-9]
Figure 1.

mg dose [15]. The volume of distribution is about 0.9L/kg.
About 10 to 20% of the drug is bound to red blood cells
[16]. Acetaminophen appears to be widely distributed
throughout most body tissues except for fat.
Paracetamol is metabolized primarily in the liver. The
major route of metabolization consists in glucuronidation
and sulfation. The products are then eliminated mainly in
the urine. Additionally, 25–35% of paracetamol is
converted into sulfate by means of the sulfation enzymes
SULT1A1, SULT1A3, and SULT1E1 [17].
A second minor metabolic pathway (5-15%) of
acetaminophen metabolization is oxidation by cytochrome
P450 enzymes. The metabolite form that results is known
as NAPQI (N-acetyl-p-benzoquinone imine) [17]. This
metabolite is an N-hydroxylate derivative and it is
responsible for all systemic damages caused by
paracetamol. In normal conditions, this metabolite is
detoxified by conjugation with glutathione. After
conjugation with glutathione, this metabolite becomes nontoxic, because it is inactive.
The non-toxic conjugate APAP-GSH is taken up in the
bile and further degraded into mercapturic and cysteine
conjugates that are excreted in the urine.
GSH is a tripeptide that consists in the amino acids
cysteine, glycine, and glutamate (Figure 2).

Figure 1. The chemical structure of Acetaminophen
(PubChem)

Discussion
Pharmacokinetics and the mechanism of action
Acetaminophen is rapidly absorbed from the
gastrointestinal (GI) tract and reaches the therapeutic levels
within 30 minutes to 2 hours. Acetaminophen has an
elimination half-life of 2 hours, but it can also last up to 17
hours in patients with hepatic dysfunction.
Mechanism of action
Paracetamol inhibits prostaglandin synthesis by
reducing the active form of COX-1 and COX-2 enzymes.
The paracetamol metabolite AM404 has been detected in
the brains of animals and in the cerebrospinal fluid of
humans after paracetamol administration [10,11].
The induction of fever is mediated by the release of
pyrogenic cytokines, such as tumor necrosis factor α,
interleukin 1, and interleukin 6 [12,13]. Honarmand et al.
found that intravenous paracetamol significantly decreases the
levels of Il-6 in patients in septic conditions in the ICU [14].
Paracetamol's bioavailability is dose-dependent: it
increases from 63% for a 500-mg dose to 89% for a 1,000-

Figure 2. The structure of Glutathione (PubChem)
It possesses sulfhydryl donor groups and it can act as a
powerful intracellular reducing agent and an antioxidant,
whilst being converted into its oxidized form, glutathione
disulfide (GSSG) [18]. The rate and the extent of GSH
synthesis depend upon the local availability of cysteine,
which is normally found in comparatively low
concentrations in hepatocytes compared to other tissues
[19].
Mechanisms of toxicity in paracetamol overdose
In paracetamol overdose, a large amount of NAPQI is
conjugated with glutathione, and this process is due to a
major depletion of glutathione. NAPQI binds to the
mitochondria proteins of the liver cells causing oxidative
stress and toxicity [17]. There is individual sensitivity to
toxic doses of paracetamol. Some patients with toxic
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concentrations of paracetamol in the plasma develop forms
of fetal liver failure [20].
Another minor direction of metabolism is the
deacetylation of 1–2% of paracetamol to form paminophenol. P-Aminophenol is then converted within the
brain by fatty acid amide hydrolase into AM404, a
compound that may be partially responsible for the
analgesic action of paracetamol [10].
Harmless in low doses, acetaminophen has direct
hepatotoxic potential when taken in an overdose and it can
cause acute liver injury and death due to acute liver failure.
Even in therapeutic doses, acetaminophen can cause
transient serum aminotransferase elevations, especially in
patients with existing comorbidities.
Acetaminophen may inhibit the nitric oxide (NO)
pathway mediated by a variety of neurotransmitter
receptors including N-methyl-D-aspartate (NMDA) and
substance P, resulting in the elevation of the pain threshold.
The antipyretic activity may result from the inhibition of
prostaglandin synthesis and the release in the central
nervous system (CNS) and the prostaglandin-mediated
effects on the heat-regulating center in the anterior
hypothalamus.
In acute intoxication, acetaminophen causes
centrilobular liver necrosis. The necrosis of more than 60%
of all hepatocytes causes fatal liver failure. Changes in
secondary myocardial necrosis and subendocardial
hemorrhage have also been reported.
Clinical signs of Paracetamol overdose
Acetaminophen toxicity is the second most common
cause of liver transplantation worldwide. More than 60
million Americans use acetaminophen on a weekly basis,
and many are unaware that it is contained in combined
products [19-21].
The clinical course of acetaminophen toxicity may be
divided into four stages [17]:
− Onset - during the first stage (30 min. to 24 hours), the
patient may be asymptomatic or may have nausea,
vomiting, anorexia, lethargy, diaphoresis.
− In the second stage - the latency stage (24 hours to 48
hours), the symptoms seem to be reduced almost
entirely, but, paraclinically, the transaminases,
bilirubin, and prothrombin time change.
− In the third stage (72 hours to 96 hours), liver
dysfunction is significant, which might lead to renal
failure, coagulopathies, metabolic acidosis, and
encephalopathy. In this stage, renal tubular necrosis
may occur, these features being known as the
hepatorenal syndrome. Gastrointestinal (GI) symptoms
reappear, and death is most common at this stage.
− The fourth stage (4 days to 3 weeks) is marked by
recovery.
104

The diagnosis and management of Paracetamol
intoxication
The diagnosis of Paracetamol intoxication is based on
anamnestic elements, symptomatology, and paraclinical
changes. Among the methods for identifying paracetamol,
there are the colorimetric ones, or more precise methods,
i.e. the chromatographic methods: Gas chromatography
combined with mass spectrometry, HPLC. Biological
samples must be withdrawn at least 4 hours after ingestion.
The diagnosis of acetaminophen toxicity is based on the
serum levels of the drug. Other important laboratory
evaluations should include liver function tests and
coagulation profiles.
In the therapeutic dose, acetaminophen is massively
excreted in the urine as various conjugated compounds, for
example as glucuronide-44-55% conjugate, 20-30% as
sulfate, and 15-55% as a conjugated cysteine and
mercapturic acid. Approximately 2% of the dose is
eliminated unchanged. The overdose saturates the
conjugate pathways and the glutathione reserve begins to
deplete, leading to the formation of a highly active
metabolite of acetaminophen, possibly an epoxide, a toxic
intermediate that irreversibly combines with the
constituents of the hepatocyte causing cell disruption
[22,23].
Acetaminophen plasma concentrations in patients with
an overdose may be between 30-300 mg/ L, and the halflife of the substance is considered to be a good indicator of
hepatic impairment. For example, researchers looked at the
changes in the serum levels of some microRNAs
(miRNAs) after the exposure of mice to acetaminophen
and their correlation with the severity of liver
histopathological lesions modified in the early stages, even
before the histopathological changes. It may be a
biomarker of toxic liver damage, but miRNA-192 cannot
be considered a sufficiently sensitive and specific
biomarker for toxic liver damage [24,25].
The Laboratory of Analytical Toxicology plays an
important role in the confirmation and the treatment of
acetaminophen intoxication. The concentrations of
acetaminophen in the serum or plasma depend on the time
elapsed from ingestion to sample collection, on the
conditions of collection and storage of the sample, but also
the individual variations in the absorption, distribution,
metabolism, and elimination of acetaminophen. In clinical
toxicology, the chemical analysis is performed for
diagnostic, therapeutic, and, over time, legal purposes.
There are many methods for determining the serum level
of acetaminophen, but they are often time-consuming,
demanding, and require the use of expensive specialized
tools.
The most used analytical methods are liquid and gas
chromatographic methods, UV spectrophotometry
methods, and immunochemical colorimetric methods.
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Due to the possibility of separating nanograms of
substance from an environment as complex as the
biological product, chromatography has proved its true
value, arousing special interest for toxicological analysis.
Among the chromatographic methods, we mention thin
layer chromatography, gas chromatography, highperformance liquid chromatography (HPLC), gaschromatographic method combined with mass
spectrometry, in order to identify the substances in the
matrix obtained from biological samples [26].
In comparison with chromatographic techniques,
electrochemical sensors can be directly applied to provide
real-time sample information. Various electrochemical
techniques, cyclic voltammetry, differential pulse
voltammetry, and square wave voltammetry have been
mostly employed in the determination of acetaminophen
with high sensitivity. Immunochemical methods use an
antibody specific for the acetaminophen molecule and a
labeled form thereof.
The fast and semi-automatic immunochemical methods
are EMIT (Enzyme Multiplied Immunoassay Technique)
and FPIA (Fluorescence Polarization Immunoassay
Technique). For example, the determination of serum
acetaminophen by EMIT in Kinetic mode with a
measurement time of at least 132 seconds at a wavelength
of 340 nm is performed using a 6-point calibration curve
using Emit® tox TM Syva concentration calibrators. 0, 10,
25, 50, 100, respectively 200 µg / ml (Figure 3).

Figure 3. Calibration curve plotted with Emit® tox
TMD acetaminophen calibrators/controls Syva® in the
range 0-150 µg / ml on the Siemens Viva-ProE analyzer
In this way, the normal (therapeutic) concentrations of
serum acetaminophen are within the range of 10-30 µg/ ml
for healthy subjects [27].
Colorimetric techniques are commonly used in clinical
laboratories, but they may interfere with acetaminophen
metabolites, salicylates, phenacetin, or hemolyzed serum.
More than 30 years ago, Gupta RM et al. described a
colorimetric method for the emergency determination of
plasma acetaminophen. Acetaminophen was extracted into
ethyl acetate at a physiological pH in order to remove
salicylate, amino acids, and other polar compounds. The
extract is treated with anhydrous sodium sulfate to remove
traces of aqueous droplets containing protein or uric acid
[28]. In 2001, Afshari and Liu described a rapid method for
the determination of serum acetaminophen by means of the

spectrophotometric
method.
Unconjugated
free
acetaminophen is separated from other endogenous
interferences by its extraction into ethyl acetate and
hydrolysis to p-aminophenol by heat and acid treatment.
The latter compound is capable of undergoing an oxidative
coupling reaction with sodium periodate-catalyzed pxylene (2,5-dimethylphenol). The resulting indophenol
derivative is measured spectrophotometrically at 635 nm.
The proposed method has a linearity range from 25 to 600
µg / ml [29,30].
Chromatographic separation techniques have been
commonly used for the determination of acetaminophen.
LC-MS methods are more common than GC-MS methods
because acetaminophen is a non-volatile compound and for
the GC-MS analysis of acetaminophen, derivatization
plays a key role. The modern chromatographic methods for
acetaminophen which are currently used are MS and
MS/MS detection and other detection methods, such as
diode array detector (DAD) [30-32].
The development and validation of the highperformance liquid chromatography (HPLC) analysis
using a Dionex Ultimate 3000 liquid chromatograph
equipped with a multidimensional detector was established
by de Ohriac et al [33]. After determining the optimum
conditions of analysis (80/20 water/ acetonitrile mobile
phase, flow rate 1.0 mL/ min, detection wavelength 245
nm), the method was validated with the following
parameters: linearity of response function, linearity of
results, limit (LD = 0.66 µg/ mL) and quantification limit
(LQ = 2.00 µg/ mL) [34,35].
The mass spectrum of acetaminophen (MW = 151) is
characterized by a baseline spectral line with m/ z 109
formed by hydrogen transfer from the methyl group of the
acetyl fragment to ionized nitrogen, the mass spectral line
m/ z 151, and a spectral line of m/ z 43 resulting from
dissociation, with the formula C2H3O.
A GC-MS method for the identification of
acetaminophen in urine was developed using a capillary
gas chromatography-mass spectrometry with ion trap
system Saturn 2000 GC 3800, with autosampler 3200 CX;
the column used was FactorFour 30m x 0.25mm, ID
DF=1.0 Varian/Chrompack. The operative parameters:
Manifold temperature – 80oC; Ion trap temperature –
170oC; Acceleration voltage – 70 eV; The mass range 50–
450 amu; The injector temperature – 300oC; The interface
GC-MS temperature – 260oC; Carriere gas – He; The
column flow 1.2 ml/min. The temperature program for the
column was set to start at a 1400 C level for 2 minutes,
followed by a temperature increase of 50C/ min to a 2900C
level for 13 minutes.
The confirmation of the identity of the compounds is
based on the comparison between the mass spectrum and
the ratio of the abundance of reference ions of each analyst
identified in the sample and those of the standards, using
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the mass spectrum library. NIST98 and PMW (Pfleger Maurer – Weber) spectral libraries were used to identify
the spectra obtained.
Following the analysis of the urine sample, the total
chromatogram is shown in Figure 4, and thus the following
compounds have been identified and are presented in Table
1: ibuprofen, acetaminophen, caffeine, chlorpheniramine.

paracetamol (compound 2), nicotine (compound 3), 3methoxyparacetamol (compound 4), and caffeine
(compound 5) were identified (Figure 5).

Table 1. The analytical data on identified compounds
The identified
compound

Molecular Retention CAS. No.
weight
time
(atomic mass
(min)
units)

Ibuprofen

206

14,864

15687-271

Acetaminophen

151

18,783

103-90-2

Caffeine

194

19,550

58-08-2

Chlorphenamine

274

22,717

132-22-9

On the ion chromatogram total, the chromatographic
peak belonging to the acetaminophen compound can be
observed at 18.783 minutes, a compound identified using
the NIST98 library (Figure 4).

Figure 5. Total chromatogram ion and the mass
spectrum obtained 3-methoxyparacetamol after the
injection of 1µL of urinary extract into GC MSD QQQ
8890/7010 AGILENT
Gas chromatography with or without derivatization is
the most specific technique. HPLC is sensitive and specific
and it has the advantage of being used to measure the
conjugated metabolites of acetaminophen in the blood and
urine.
The determination of serum acetaminophen levels by
TDM (Therapeutic Drug Monitoring) in the case of acute
intoxications is important both for making the diagnosis of
certainty, and especially for the correct application of the
medical measures that are required mainly due to its high
hepatotoxicity.
The therapeutic approach in suspected Paracetamol
toxicity

Figure 4. Total chromatogram ion and the mass
spectrum obtained for Acetaminophen after the injection
of 1µL of urinary extract into GC/ MS, with ion hatch in
EI.
Another qualitative determination of acetaminophen
and its major metabolite (3-methoxyparacetamol) from
urine is presented using the gas chromatograph system
combined with the mass spectrometer (GC-MS)
quadrupole type, GC MSD QQQ 8890/7010 AGILENT
with Agilent column HP25 5m2 Ultra, Um Splitless
injection, Injected volume 1 ul, Injector temperature:
280°C, Carrier gas: He, with a total flow of 2.25 ml/ min;
column flow: 1.1 ml/min, Detection mode: SCAN
In this case, the operative parameters for the mass
spectrometer are: The source temperature = 2,300 C, the
temperature on the first quadrupole = 1,500 C, the
temperature on the second quadrupole = 1,500 C, the
filament current = 100 microA, the type of ionizationelectronics, the acceleration voltage = 70 eV.
MSD operates in Full SCAN mode and on analysis of
the chromatogram obtained, ibuprofen (compound 1),
106

Several factors were associated with an increased risk
of Paracetamol toxicity, such as acute or chronic
malnutrition, alcohol consumption. Diabetes mellitus and
hyperglycemia were found to exacerbate acetaminopheninduced acute liver injury due to an increased level of
oxidative stress and low-grade chronic inflammation [3638]. Wide inter-individual variability was correlated with
the numerous genes that may interfere with its
pharmacokinetics and metabolization. Severe liver injury,
along with the increasing expressions of NLRP3 and IL1β, occurred in acetaminophen-treated mice liver or liver
cell lines [39-41], while genetic deficiencies in NLRP3
inflammasome components (NLRP3, ASC, and caspase-1)
were found to provide some degree of protection from
acetaminophen-induced mice death and liver injury [42].
The toxicity of the drug in children below 12 years of age
is still a controversial topic. However, there is evidence
that the metabolization of the drug occurs predominately
by sulfation if compared to adults, and no oxidation
metabolism products were found in the children’s plasma.
The prenatal exposure to paracetamol was found to be
associated with an increased risk of attention disorders and

Acetaminophen, a therapeutic or an extremely toxic remedy – a review

ADHD, while these effects were not registered in postnatal
exposure [43,44].
Phenobarbital-type enzyme inducers intensify the
activity of oxidases with mixed microsomal functions,
increasing the percentage of toxic metabolite and
increasing the hepatotoxicity of paracetamol [45].
In order to reduce the systemic toxicity of Paracetamol
and the functional recovery of the liver, Acetylcysteine is
used as a specific antidote. Acetylcysteine is a prodrug of
L-cysteine, which is a precursor of glutathione [46].
Acetylcysteine prevents GSH depletion and minimizes the
hepatocyte injury caused by several different toxins. The
potent electron donor properties of acetylcysteine and the
consequent ability to lessen oxidative stress might be
another independent mechanism that protects against acute
liver injury [47].
Since N-acetylcysteine (NAC) is a precursor of
glutathione, it increases the concentration of glutathione
available for the conjugation of N-acetyl-p-benzoquinone
imine (NAPQI) a toxic byproduct produced during the
xenobiotic metabolism of Paracetamol [48]. The
intravenous infusion regimen was developed to give the
highest tolerated dose as quickly as possible because of the
short-time window of therapeutic efficacy. NAC works
through multiple routes. It prevents the binding of NAPQI
to hepatic macromolecules, it acts as a substitute for
glutathione, it is a precursor for sulfate, and it reduces
NAPQI back to acetaminophen. The indications for NAC
include serum levels that fall in the toxic range according
to the Rumack-Matthew nomogram. The Rumack–
Matthews nomogram or acetaminophen can be used to
predict hepatotoxicity when the time of ingestion is known
or a reference determination is made to allow the
calculation of the Paracetamol half-life and the evaluation
of the prognosis. It is a logarithmic graph starting not
directly from ingestion, but from the 4 hour-post-ingestion
after absorption is considered likely to be complete [4951].
The NAC administration should still be attempted and
it may improve survival even in delayed presentations, as
it can act as an antioxidant that diminishes hepatic necrosis,
decreases
neutrophil
infiltration,
improves
microcirculatory blood flow, and increases tissue oxygen
delivery [52]. Acetylcysteine is extensively liver
metabolized, CYP450 minimal, urine excretion is 22-30%
with a half-life of 5.6 hours in adults and 11 hours in
neonates. Hemodialysis can also be an effective treatment,
especially with concurrent renal failure [52,53].
The overall prognosis of patients depends on the
following criteria: creatinine levels higher than 3.4 mg/dL;
arterial pH remaining lower than 7.3, despite the adequate
fluid hydration; prothrombin time more than 1.8 times
control or an INR of more than 6.5; the development of
grade 3 or 4 encephalopathies [52-54].

Highlights
✓ Paracetamol is one of the most used over-the-counter
medicines, but also a leading cause of toxic liver
failure.
✓ The evaluation of serum acetaminophen levels by
analytical methods is extremely useful both for the
diagnosis and the therapeutic monitoring.

Conclusions
Paracetamol is one of the most used over-the-counter
medicines, even after more than 100 years after its
discovery, being a very efficient antipyretic and analgesic
drug. In overdoses, it remains an important cause of
morbidity, mortality and associated costs in healthcare
worldwide. Understanding the metabolic pathways, the
clinical signs, and the risk factors of systemic toxicity is
important to prevent irreversible organ damage. The
determination of serum acetaminophen levels by analytical
methods is extremely useful both for diagnosis and the
therapy monitoring.
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